-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TwRc6xC7Fosmfw6hPJByo+FGGUXn2WaclLzCBZ/qIZswdN6mM6OUmDPVhFeeSfq0 FFlLc2a1pGnKg/4HZrHcHg== 0001104659-05-045862.txt : 20060914 0001104659-05-045862.hdr.sgml : 20060914 20050927103455 ACCESSION NUMBER: 0001104659-05-045862 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 CORRESP 1 filename1.htm

 

[SG Cowen & Co., LLC Letterhead]

 

 

 

September 27, 2005

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 03-08

Washington, D.C.  20549

 

Attention:  Mr. Zafar Hasan Esq.

 

Re:          Sunesis Pharmaceuticals, Inc.

Registration Statement on Form S-1 (File No. 333-121646)

 

Ladies and Gentlemen:

 

As representative of the undersigned underwriters of the proposed initial public offering of up to 6,000,000 shares of common stock of Sunesis Pharmaceuticals, Inc., we hereby represent to the Staff of the U.S. Securities and Exchange Commission that the normal channels of communications between the underwriters and potential purchasers are being and would be used to inform such potential purchasers of (1) the change in the offering price, (2) the indications of interest submitted by the Company’s existing stockholders and (3) the amount of the deemed dividend prior to confirming sales.  In addition, a copy of the final prospectus will accompany each confirmation notice.

 

 

 

Very truly yours,

 

 

 

LEHMAN BROTHERS INC.

 

SG COWEN & CO., LLC

 

NEEDHAM & COMPANY, LLC

 

 

 

 

BY:

SG COWEN & CO., LLC

 

 

 

 

BY:

/S/ GRAHAM POWISS

 

 

 

Graham Powiss,

 

 

Managing Director

 

 -----END PRIVACY-ENHANCED MESSAGE-----